Dr. Sarah Larson is an Assistant Professor in the Division of Hematology-Oncology at the David Geffen School of Medicine at UCLA. She received her medical degree at the University of Minnesota and completed her postgraduate training at the University of Chicago and UCLA. During her fellowship at UCLA, Dr. Larson studied the function of chimeric antigen receptors in hematopoietic stem and progenitor cells under the mentorship of Dr. Donald B. Kohn. She joined the faculty at UCLA in 2013 and her research focuses on the development of engineered cell therapy trials for mature B cell malignancies. She is currently the Director of the Multiple Myeloma Program and the Director of the Outpatient Cellular Therapy and Hematologic Malignancies Clinic at UCLA.